Regeneron Pharmaceuticals, Inc 10-K for FY2025
Regeneron Pharmaceuticals, Inc. (REGN)
10-K
2026-02-04
For: 2025-12-31
View Original
Added on
April 08, 2026
About this 10-K
Regeneron Pharmaceuticals, Inc filed this 10-K on February 4, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $14.34B
- up 1.0% from $14.2B a year earlier
- Net income
- $4.5B
- up 2.1% from net income of $4.41B a year earlier
- Diluted EPS
- $41.48
- up 8.2% from $38.34 a year earlier